Squamous Cell Carcinoma, Serum
Useful as a tumor marker for squamous cell carcinomas of the head and neck, uterine cervix, lung, vulva, and esophagus.
New York DOH Approval Status
Serum separator tube or plain red.
Allow specimen to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Specimens exposed to repeated freeze/thaw cycles.
After separation from cells: Ambient: 48 hours; Refrigerated: 14 days; Frozen: 2 months
This test is performed using the BRAHMS SCC Kryptor kit. Results obtained with different assay methods or kits cannot be used interchangeably. SCC Antigen levels alone should not be interpreted as evidence of the presence or absence of malignant disease. In patients with known or expected cancer, other tests and procedures must be considered for diagnosis and patient management. Elevated concentrations may also occur in benign conditions such as gynecological diseases, inflammatory lung disease, and liver or renal insufficiency.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*
|Component Chart Name
|Squamous Cell Carcinoma, Serum
- SCC Antigen